osteobionix is a Spanish biotechnology startup founded in 2018 with the slogan "From replacement to regeneration." The company is committed to raising the standards of care for individuals suffering from cartilage or bone loss caused by factors such as osteoarthritis, trauma, or tumors, significantly impacting their quality of life. osteobionix's goal is to offer innovative, high-quality, and customized solutions to individuals dealing with cartilage or bone loss, aiding them in reclaiming their deserved lifestyle. The company collaborates with surgeons to develop and produce reliable, cost-effective solutions tailored to the uniqueness and intricacy of each surgical case. By aspiring to lead the industry in transitioning from replacement to regeneration in cartilage and bone surgery, osteobionix aims to establish itself as an industry pioneer. Launched as a spin-off of the Canary Islands Institute of Technology (ITC – Instituto Tecnológico de Canarias), osteobionix's team has been dedicated to developing innovative bone and cartilage reconstruction and regeneration solutions within the ITC Department of Biomedical Engineering since 2006. As of now, there is no available information regarding the last investment received by osteobionix, or the involved investors. The startup operates primarily in the Biotechnology and Health Care industries.
There is no investment information
No recent news or press coverage available for osteobionix.